Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial
2010 Standout
Electrocardiography of myocarditis revisited: Clinical and prognostic significance of electrocardiographic changes
1992
Balloon pulmonary valvuloplasty: Results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry
1990
Universal Definition of Myocardial Infarction: Clinical Insights
2015 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
New P2Y12Inhibitors Versus Clopidogrel in Percutaneous Coronary Intervention
2010
Surface engineering of electrospun polyethylene terephthalate (PET) nanofibers towards development of a new material for blood vessel engineering
2004
Clinical results of carotid artery stenting compared with carotid endarterectomy
2008
New Antithrombotic Drugs
2012
Exercise Standards for Testing and Training
2013 Standout
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Adverse Effects of Amiodarone
1998
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Management of atrial fibrillation in patients with heart failure
2007
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data
2013
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Amiodarone Is Poorly Effective for the Acute Termination of Ventricular Tachycardia
2005
Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms
2008
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial
2011 Standout
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article
2002
Balloon aortic valvuloplasty: Results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry
1990
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
2018 Standout
The Year in Non–ST-Segment Elevation Acute Coronary Syndrome
2010
Pharmacologic Management of Supraventricular Tachycardias in Children
1997
Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia
2002
Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery
2012
Reduced immediate ischemic events with cangrelor in PCI: A pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction
2012
Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
2010
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
2008
Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation
1996
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article
2002
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary
2011
Re-Stenosis after Successful Coronary Angioplasty
1988
Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation
2010
Electrospinning: Applications in drug delivery and tissue engineering
2008 Standout
Electrospinning: A Fascinating Method for the Preparation of Ultrathin Fibers
2007 Standout
Part 8: Advanced life support
2010
Percutaneous Transluminal Coronary Angioplasty
1994
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
Endovascular treatment of cerebrovascular diseases and intracranial neoplasms
2004
Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment?
2007
In vitro evaluation of electrospun nanofiber scaffolds for vascular graft application
2007
Myocarditis
2009 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Role of electrophysiologic testing in the diagnosis and treatment of patients with known and suspected bradycardias and tachycardias
1981
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Percutaneous transluminal angioplasty and stenting for carotid artery stenosis
2004
Therapeutic Potential of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in the Management of Ischemic Stroke
2003
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Antiplatelet and Anticoagulation Therapy for Acute Coronary Syndromes
2014
Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
2011
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Targeting G βγ signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis
1999 StandoutNobel
Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis
2012
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
Bundle branch block and sudden death
1980
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
The platelet P2Y12 receptor for adenosine diphosphate: congenital and drug-induced defects
2010
Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
1997 Standout
2012 Update to The Society of Thoracic Surgeons Guideline on Use of Antiplatelet Drugs in Patients Having Cardiac and Noncardiac Operations
2012
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Recent Developments in the Chemistry of Cubic Polyhedral Oligosilsesquioxanes
2010 Standout
Sympatholytic Action of Intravenous Amiodarone in the Rat Heart
1995
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Part 8: Post–Cardiac Arrest Care
2015 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
UV surface modification of a new nanocomposite polymer to improve cytocompatibility
2007
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
2010
Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis.
1989
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
A Prospective Evaluation and Follow-up of Patients with Syncope
1983 Standout
Works of F Leisch being referenced
[Percutaneous pulmonary valvuloplasty in adults].
1986
Adhesion and proliferation of human endothelial cells on photochemically modified polytetrafluoroethylene
2003
Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study
2007
Platelet Inhibition with Cangrelor in Patients Undergoing PCI
2009
Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate
2005
Influence of a variant angina on the results of percutaneous transluminal coronary angioplasty.
1986
Abciximab Bolus Injection Does Not Reduce Cerebral Ischemic Complications of Elective Carotid Artery Stenting
2002
Predictors of Death and Stroke After Carotid Angioplasty and Stenting
2008
The HQ time in congestive cardiomyopathies
1979
Pro-CAS
2004
Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation.
1989
R-Amplituden-Veränderung und ST-Strecken-Senkung im Belastungs-EKG im Vergleich mit angiographischen Befunden
2008
Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report
1987